Research Article

Interleukin 35 Polymorphisms Are Associated with Decreased Risk of Premature Coronary Artery Disease, Metabolic Parameters, and IL-35 Levels: The Genetics of Atherosclerotic Disease (GEA) Study

Table 5

Association between EBI3 and IL-12A gene polymorphisms and metabolic abnormalities in the control group.

PolymorphismGenotype frequency (%)MAFModel OR [95% CI]

(i) EBI3
rs428253G>C
GGGCCC
Hyperuricemia
 No ()454 (0.625)220 (0.303)52 (0.072)0.223Heterozygote1.595 [1.064–2.389]0.024
 Si ()82 (0.555)57 (0.390)8 (0.055)0.248Codominant 11.567 [1.038–2.365]0.032
rs4740G>A
GGGAAA
Central obesity
 No ()99 (0.503)78 (0.400)19 (0.097)0.296Heterozygote0.391 [0.163–0.937]0.035
 Si ()377 (0.557)251 (0.371)49 (0.072)0.258Codominant 20.386 [0.157–0.949]0.038
AST > p75Additive1.250 [1.004–1.557]0.046
 No ()327 (0.576)197 (0.348)43 (0.076)0.250Dominant1.430 [1.076–1.899]0.014
 Si ()148 (0.485)133 (0.433)25 (0.082)0.299Heterozygote1.433 [1.073–1.913]0.015
Codominant 11.473 [1.093–1.985]0.011
rs4905A>G
AAAGGG
Central obesity
 No ()99 (0.503)78 (0.400)19 (0.097)0.296Recessive0.404 [0.170–0.960]0.040
 Si ()374 (0.552)253 (0.371)50 (0.074)0.261Codominant 20.403 [0.165–0.983]0.046
AST > p75Dominant1.399 [1.054–1.858]0.020
 No ()324 (0.571)199 (0.352)44 (0.078)0.253Heterozygote1.410 [1.056–1.882]0.020
 Si ()148 (0.485)133 (0.433)25 (0.082)0.299Codominant 11.445 [1.072–1.946]0.016
(ii) IL-12A
rs568408G>A
GGGAAA
Metabolic syndrome
 No ()542 (0.883)69 (0.112)3 (0.005)0.061Additive0.583 [0.347–0.981]0.042
 Si ()237 (0.915)21 (0.081)1 (0.004)0.044
rs583911A>G
AAAGGG
SAT > p75
 No ()129 (0.268)222 (0.459)132 (0.273)0.503Heterozygote1.776 [1.203–2.622]0.004
 Si ()88 (0.226)220 (0.563)82 (0.211)0.492Codominant 11.776 [1.107–2.849]0.017

Table shows the models with significant associations. Models were adjusted for age, gender, and body mass index. MAF: minor allele frequency, AST: aspartate aminotransferase, and SAT: subcutaneous adipose tissue.